ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,286 | +15.7% | 1,073 | +3.9% | 0.00% | – |
Q2 2023 | $10,619 | +88391.7% | 1,033 | -31.1% | 0.00% | – |
Q1 2023 | $12 | +50.0% | 1,499 | +46.8% | 0.00% | – |
Q4 2022 | $8 | -99.9% | 1,021 | -36.3% | 0.00% | – |
Q3 2022 | $12,000 | -93.3% | 1,604 | -92.4% | 0.00% | -100.0% |
Q2 2022 | $180,000 | +900.0% | 21,209 | +958.3% | 0.00% | – |
Q1 2022 | $18,000 | +63.6% | 2,004 | +148.9% | 0.00% | – |
Q4 2021 | $11,000 | -47.6% | 805 | -59.5% | 0.00% | -100.0% |
Q3 2021 | $21,000 | +200.0% | 1,988 | +178.4% | 0.00% | – |
Q2 2021 | $7,000 | -30.0% | 714 | -28.2% | 0.00% | – |
Q1 2021 | $10,000 | +150.0% | 995 | +243.1% | 0.00% | – |
Q4 2020 | $4,000 | -96.7% | 290 | -97.9% | 0.00% | -100.0% |
Q3 2020 | $120,000 | +5900.0% | 13,645 | +7609.0% | 0.00% | – |
Q2 2020 | $2,000 | – | 177 | +98.9% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 89 | -85.9% | 0.00% | – |
Q1 2019 | $4,000 | -63.6% | 633 | -78.9% | 0.00% | -100.0% |
Q4 2018 | $11,000 | +37.5% | 2,995 | +138.6% | 0.00% | 0.0% |
Q3 2018 | $8,000 | -20.0% | 1,255 | -6.1% | 0.00% | 0.0% |
Q2 2018 | $10,000 | +900.0% | 1,337 | +1292.7% | 0.00% | – |
Q1 2018 | $1,000 | -90.0% | 96 | -89.2% | 0.00% | -100.0% |
Q4 2017 | $10,000 | – | 885 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 3,056,420 | $22,006,000 | 19.85% |
Decheng Capital Management III (Cayman), LLC | 6,708,288 | $48,300,000 | 17.51% |
GREAT POINT PARTNERS LLC | 3,448,521 | $24,829,000 | 5.98% |
Omega Fund Management, LLC | 2,029,580 | $14,613,000 | 5.35% |
Paradigm Biocapital Advisors LP | 2,214,722 | $15,946,000 | 2.13% |
Frazier Life Sciences Management, L.P. | 2,985,757 | $21,497,000 | 1.66% |
COMMODORE CAPITAL LP | 1,325,000 | $9,540,000 | 1.53% |
Octagon Capital Advisors LP | 1,225,000 | $8,820,000 | 1.52% |
RA Capital Management | 4,356,632 | $31,368,000 | 0.67% |
TCG Crossover Management, LLC | 254,569 | $1,833,000 | 0.55% |